Matsuyama Y - Search Results

1

A comparison of error detection rates between the reading aloud method and the double data entry method.

Kawado M, Hinotsu S, Matsuyama Y, Yamaguchi T, Hashimoto S, Ohashi Y. Kawado M, et al. Among authors: matsuyama y. Control Clin Trials. 2003 Oct;24(5):560-9. doi: 10.1016/s0197-2456(03)00089-8. Control Clin Trials. 2003. PMID: 14500053

2

Mixed models for bivariate response repeated measures data using Gibbs sampling.

Matsuyama Y, Ohashi Y. Matsuyama Y, et al. Stat Med. 1997 Jul 30;16(14):1587-601. doi: 10.1002/(sici)1097-0258(19970730)16:14<1587::aid-sim592>3.0.co;2-l. Stat Med. 1997. PMID: 9257414 Clinical Trial.

3

A Bayesian hierarchical survival model for the institutional effects in a multi-centre cancer clinical trial.

Matsuyama Y, Sakamoto J, Ohashi Y. Matsuyama Y, et al. Stat Med. 1998 Sep 15;17(17):1893-908. doi: 10.1002/(sici)1097-0258(19980915)17:17<1893::aid-sim878>3.0.co;2-r. Stat Med. 1998. PMID: 9777685 Clinical Trial.

4

An analysis of institutional effects in a multicenter cancer clinical trial: is it also plausible from the clinicians' point of view?

Sakamoto J, Matsuyama Y, Ohashi Y. Sakamoto J, et al. Among authors: matsuyama y. Jpn J Clin Oncol. 1999 Aug;29(8):403-5. doi: 10.1093/jjco/29.8.403. Jpn J Clin Oncol. 1999. PMID: 10494927 No abstract available.

5

Trends in HIV and AIDS based on HIV/AIDS surveillance data in Japan.

Matsuyama Y, Hashimoto S, Ichikawa S, Nakamura Y, Kidokoro T, Umeda T, Kamakura M, Kimura S, Fukutomi K, Ikeda C, Kihara M. Matsuyama Y, et al. Int J Epidemiol. 1999 Dec;28(6):1149-55. doi: 10.1093/ije/28.6.1149. Int J Epidemiol. 1999. PMID: 10661661

6

Delays and continuation of hospital visits among HIV-infected persons and AIDS cases in Japan.

Hashimoto S, Matsumoto T, Nagai M, Matsuyama Y, Nakamura Y, Umeda T, Kamakura M, Ichikawa S, Kimura S, Fukutomi K, Kihara M. Hashimoto S, et al. Among authors: matsuyama y. J Epidemiol. 2000 Jan;10(1):65-70. doi: 10.2188/jea.10.65. J Epidemiol. 2000. PMID: 10695263 Free article.

7

Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.

Matsuyama Y, Tominaga T, Nomura Y, Koyama H, Kimura M, Sano M, Miura S, Takashima S, Mitsuyama S, Ueo H, Ohashi Y. Matsuyama Y, et al. Ann Oncol. 2000 Dec;11(12):1537-43. doi: 10.1093/oxfordjournals.annonc.a010406. Ann Oncol. 2000. PMID: 11205460 Free article.

8

Estimation and comparison of rates of change in repeated-measures studies with planned dropout.

Toyoda I, Matsuyama Y, Ohashi Y. Toyoda I, et al. Among authors: matsuyama y. Control Clin Trials. 2001 Dec;22(6):620-38. doi: 10.1016/s0197-2456(01)00166-0. Control Clin Trials. 2001. PMID: 11738120

9

Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials.

Yamaguchi T, Ohashi Y, Matsuyama Y. Yamaguchi T, et al. Among authors: matsuyama y. Stat Methods Med Res. 2002 Jun;11(3):221-36. doi: 10.1191/0962280202sm284ra. Stat Methods Med Res. 2002. PMID: 12094756

10

Vesnarinone-induced WBC disorders in Japan.

Matsuyama Y, Ohashi Y, Uchino H, Takaku F, Otsuka Y, Suzuki A. Matsuyama Y, et al. Pharmacoepidemiol Drug Saf. 1996 Mar;5(2):87-93. doi: 10.1002/(SICI)1099-1557(199603)5:2<87::AID-PDS225>3.0.CO;2-8. Pharmacoepidemiol Drug Saf. 1996. PMID: 15073836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,054 results

Search Page

Filters